Guidant and Micro expand European agreement:
This article was originally published in Clinica
Executive Summary
Guidant is to have exclusive European distribution rights to Micro Therapeutics' Embolyx technology for peripheral vascular emobolisation applications. Guidant gained exclusive distribution rights to Micro's neurovascular products in Europe in November 1997. Under the original deal, Guidant agreed to invest up to $10 million in the San Clemente, California-based company. $7.5 million has been paid to date. The remaining $2.5 million is subject to Micro achieving a milestone by the end of the year.